Chronic Aflatoxin Exposure and Cognitive and Language Development in Young Children of Bangladesh: A Longitudinal Study

Toxins (Basel). 2022 Dec 3;14(12):855. doi: 10.3390/toxins14120855.

Abstract

Aflatoxin can cross the blood-brain barrier, damage brain tissues, and have the potential to harm the development of the human brain. Although dietary aflatoxin exposure is common in children, there is a paucity of data on aflatoxin exposure and child developmental outcomes. The child's cognitive, motor, and language functions were assessed using the Bayley Scales of Infant and Toddler Development-III or BSID-III at the same time points. Association between exposure to aflatoxin and subtests of BSID-III were examined using mixed-effect linear regression. Aflatoxin assays were performed on 194, 167, and 163 children at 15, 24, and 36 months of age, and chronic aflatoxin exposure was detected in 20.6%, 16.8%, and 60.7% of children, respectively. Multi-variable analyses showed that aflatoxin exposure was independently related to the children's cognitive score (β: -0.69; 95% CI: -1.36, -0.02), receptive language score (β: -0.90; 95% CI: -1.62, -0.17), and expressive language score (β: -1.01; 95% CI: -1.96, -0.05). We did not observe any association between exposure to aflatoxin and the motor function of children. Chronic exposure to aflatoxin exposure was linked to reduced cognitive, expressive, and receptive language scores of the study children. Further research is needed in a different setting to confirm this novel finding.

Keywords: Bayley; aflatoxin; child development; cognitive.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aflatoxins / toxicity
  • Bangladesh / epidemiology
  • Child Development* / drug effects
  • Child, Preschool
  • Cognition* / drug effects
  • Dietary Exposure / adverse effects
  • Humans
  • Infant
  • Language Development*
  • Longitudinal Studies

Substances

  • Aflatoxins

Grants and funding

This research was funded by the Bill and Melinda Gates Foundation. The grant number is OPP1066253. The funder was not involved with study design, data collection or data analysis.